CPT code 67025 covers the intraocular injection of a vitreous substitute (gas, silicone, or spreading agent) used to replace removed vitreous or to maintain/regain intraocular pressure during vitreoretinal surgery. This procedure is clinically significant for management of retinal detachments, complicated vitreous hemorrhage, and other posterior segment conditions where a tamponade or volume replacement is required. Nationally, accurate coding for 67025 affects surgical bundling, facility payment classification, and clinical documentation for ophthalmology practices and surgical centers.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of where 67025 fits in the surgical service line, typical sites of service (hospital operating room and ambulatory surgical center), and the clinical contexts that prompt use of a vitreous substitute. The publication also summarizes common billing considerations, typical modifiers used by payers, and related coding topics relevant to claim adjudication and documentation practices.

This summary is intended for a national audience of coding professionals, surgical administrators, and clinicians seeking a concise reference on the clinical purpose, billing context, and payer landscape for CPT code 67025.